Position in LLY
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$12,122,568
-$2,308,236 QoQ
Shares Held
13,180
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Anchor Investment Management, LLC holds $69,112,010 across 15 Drug Manufacturers - General names. LLY ranks #3 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
87,612 | $21,415,877 | |
| 2 | ABBV |
AbbVie Inc.
|
87,821 | $19,100,189 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
13,180 | $12,122,568 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,472 | $7,875,626 | |
| 5 | PFE |
Pfizer Inc
|
87,568 | $2,458,909 | |
| 6 | GSK |
GSK plc
|
33,440 | $1,845,553 | |
| 7 | AMGN |
Amgen Inc
|
4,884 | $1,718,435 | |
| 8 | NVS |
Novartis AG
|
6,726 | $1,027,396 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,122,568 | 13,180 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $14,430,804 | 13,428 | Shares | Sole | 2026-02-26 | |
| 2025-09-30 | $10,872,750 | 14,250 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,955,514 | 14,054 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $11,575,954 | 14,016 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $10,842,740 | 14,045 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $12,358,863 | 13,950 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $12,644,537 | 13,966 | Shares | Sole | 2024-09-20 | |
| 2024-03-31 | $10,763,076 | 13,835 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,282,710 | 14,209 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $7,498,334 | 13,960 | Shares | Sole | 2024-01-02 | |
| 2023-06-30 | $6,501,938 | 13,864 | Shares | Sole | 2024-01-02 | |
| 2023-03-31 | $4,617,281 | 13,445 | Shares | Sole | 2024-01-02 | |
| 2022-12-31 | $4,901,890 | 13,399 | Shares | Sole | 2024-01-02 | |
| 2022-09-30 | $4,494,565 | 13,900 | Shares | Sole | 2024-01-02 | |
| 2022-06-30 | $4,546,028 | 14,021 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $4,060,153 | 14,178 | Shares | Sole | 2024-01-02 | |
| 2021-12-31 | $4,144,957 | 15,006 | Shares | Sole | 2024-01-02 | |
| 2021-09-30 | $3,430,630 | 14,848 | Shares | Sole | 2024-01-02 | |
| 2021-06-30 | $3,389,780 | 14,769 | Shares | Sole | 2024-01-02 | |
| 2021-03-31 | $2,717,670 | 14,547 | Shares | Sole | 2024-01-02 | |
| 2020-12-31 | $2,444,296 | 14,477 | Shares | Sole | 2024-01-02 | |
| 2020-09-30 | $1,965,261 | 13,277 | Shares | Sole | 2024-01-02 | |
| 2020-06-30 | $2,179,817 | 13,277 | Shares | Sole | 2024-01-02 | |
| 2020-03-31 | $1,841,785 | 13,277 | Shares | Sole | 2024-01-02 | |
| No filing history on record for this holder in this stock. | ||||||